New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control
Recruiting now
This early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that cannot be removed by surgery. About 30 participants who have tried other treatments or cannot take them will receive the drug to see if it is safe and what dose works best…
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated May 11, 2026 20:41 UTC